Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atyr Pharma Inc (LIFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 119,040
  • Shares Outstanding, K 29,760
  • Annual Sales, $ 0 K
  • Annual Income, $ -57,860 K
  • 36-Month Beta 3.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.29

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.40 +20.59%
on 12/29/17
4.10 unch
on 01/17/18
+0.50 (+13.89%)
since 12/15/17
3-Month
3.30 +24.24%
on 12/12/17
5.65 -27.43%
on 10/18/17
-1.30 (-24.07%)
since 10/17/17
52-Week
2.30 +78.26%
on 08/23/17
6.50 -36.92%
on 10/12/17
+1.65 (+67.35%)
since 01/17/17

Most Recent Stories

More News
aTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that Sanjay Shukla, M.D.,...

JPM : 112.64 (+0.33%)
LIFE : 4.20 (+5.00%)
aTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium

aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering from rare, severe, immune-mediated...

LIFE : 4.20 (+5.00%)
aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923)

- Second Physiocrine-based therapeutic candidate enters the clinic -

LIFE : 4.20 (+5.00%)
aTyr Pharma to Participate at the Piper Jaffray 29th Annual Healthcare Conference

aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering from rare, severe, immune-mediated...

LIFE : 4.20 (+5.00%)
aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

- Initiation of Phase 1 clinical trial of iMod.Fc on-track for this quarter -

LIFE : 4.20 (+5.00%)
Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval

Drug and Medical Device stocks Appreciate in Value Before Big Clinical Trial Results and Clearances from the FDA or European Medicines Agency Investors who Recognize the Potential "Lightning Strike"...

ALNY : 124.89 (+0.20%)
MNKD : 2.53 (+2.43%)
LIFE : 4.20 (+5.00%)
Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval

Drug and Medical Device stocks Appreciate in Value Before Big Clinical Trial Results and Clearances from the FDA or European Medicines Agency Investors who Recognize the Potential "Lightning Strike"...

ALNY : 124.89 (+0.20%)
MNKD : 2.53 (+2.43%)
LIFE : 4.20 (+5.00%)
aTyr Pharma Announces Leadership Transition

- Dr. John Mendlein Transitions from CEO to Non-Executive Board Member,

LIFE : 4.20 (+5.00%)
Imminent FDA Approval and Lucrative Business Model Indicate Big Near-Term Upside For BTCY

Comparables BEAT ($1 Billion, +1200% in 5 years) and IRTC ($1.4 Billion, +136% in 1 year) indicate just how hot the Cardiac Monitoring vertical is. Cardiac monitoring was a $22.2 billion market globally...

BEAT : 33.20 (+0.91%)
ATOS : 0.26 (unch)
LIFE : 4.20 (+5.00%)
Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences

Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences

GGAL : 72.00 (+0.33%)
KRA : 50.83 (+1.01%)
CALA : 8.40 (+4.35%)
SUPV : 32.95 (+0.73%)
LIFE : 4.20 (+5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators are in flux.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

2nd Resistance Point 4.13
1st Resistance Point 4.07
Last Price 4.20
1st Support Level 3.92
2nd Support Level 3.83

See More

52-Week High 6.50
Fibonacci 61.8% 4.90
Fibonacci 50% 4.40
Last Price 4.20
Fibonacci 38.2% 3.90
52-Week Low 2.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.